Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, C/Choupana S/N, 15706, Santiago de Compostela, Spain.
Department of Pharmacy, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Surg Endosc. 2021 Feb;35(2):644-651. doi: 10.1007/s00464-020-07428-4. Epub 2020 Feb 19.
Current treatment of infected pancreatic necrosis (IPN) follows a step-up approach. Our group designed a step-up protocol that associates endoscopic drainage with local infusion of antibiotics through transmural nasocystic catheter. Aim of our study was to evaluate our step-up protocol for IPN in terms of proportion of patients avoiding necrosectomy.
Retrospective analysis of patients admitted with acute pancreatitis (AP) between January 2015 and December 2018. The number of patients who responded to each therapeutic step were analysed: step 1, systemic antibiotics; step 2, endoscopic transmural drainage and local infusion of antibiotics; step 3, endoscopic necrosectomy.
1158 patients with AP were included. 110 patients (8.4%) suffered from necrotising pancreatitis; 48 of them had IPN (42.6% of necrotising pancreatitis) and were treated with systemic antibiotics. Nineteen patients (39.6% of IPN) responded and did not required any invasive therapy. Six patients with IPN on systemic antibiotics died within the first 4 weeks of disease before step 2 could be applied. Urgent surgical necrosectomy in the first 4 weeks was performed in three additional patients. Endoscopic drainage and local antibiotic therapy was performed in the remaining 20 patients; 9 (45% of them) did well and 9 patients underwent necrosectomy (18.7% of IPN). Two patients died on drainage. Overall mortality of the total cohort of AP was 2.53% CONCLUSIONS: Addition of local infusion of antibiotics to endoscopic drainage avoids the need of necrosectomy in half of patients with IPN not responding to systemic antibiotics.
目前,感染性胰腺坏死(IPN)的治疗遵循逐步升级的方法。我们的团队设计了一种逐步升级的方案,将内镜引流与通过经壁鼻囊导管局部输注抗生素相结合。我们研究的目的是评估我们的 IPN 逐步升级方案在避免坏死性切除术方面的效果。
回顾性分析 2015 年 1 月至 2018 年 12 月期间因急性胰腺炎(AP)住院的患者。分析每个治疗步骤的患者比例:第 1 步,全身抗生素治疗;第 2 步,内镜经壁引流和局部输注抗生素;第 3 步,内镜坏死性切除术。
共纳入 1158 例 AP 患者。110 例(8.4%)患有坏死性胰腺炎;其中 48 例为 IPN(坏死性胰腺炎的 42.6%),接受全身抗生素治疗。19 例(IPN 的 39.6%)患者对治疗有反应,无需任何侵入性治疗。6 例在开始第 2 步治疗前的前 4 周内死于全身抗生素治疗的 IPN 患者。另外 3 例患者在第 1 周内进行了紧急手术坏死性切除术。其余 20 例患者进行了内镜引流和局部抗生素治疗;其中 9 例(45%)病情良好,9 例患者进行了坏死性切除术(IPN 的 18.7%)。2 例患者在引流过程中死亡。AP 总队列的总死亡率为 2.53%。
在对全身抗生素治疗无反应的 IPN 患者中,局部输注抗生素联合内镜引流可避免半数患者需要行坏死性切除术。